Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years.
Alidjinou EK, Demaret J, Corroyer-Simovic B, Labreuche J, Goffard A, Trauet J, Lupau D, Miczek S, Vuotto F, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Sobaszek A, Hober D, Hisbergues M, Puisieux F, Autran B, Yazdanpanah Y, Labalette M, Lefèvre G.
Alidjinou EK, et al. Among authors: labreuche j.
Lancet Reg Health Eur. 2022 Jun;17:100385. doi: 10.1016/j.lanepe.2022.100385. Epub 2022 Apr 21.
Lancet Reg Health Eur. 2022.
PMID: 35469147
Free PMC article.